Form D · Other Health Care

Neurotrigger Ltd.

Even Yehuda, L3 · CIK 0001987476

Offering snapshot reported Dec 30, 2025 · SEC filing

Reported sold
$725K
Offering amount: $725K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 5, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 30, 2025Initial$724,980No comparison1SEC filing
Apr 22, 2025Initial$520,000No comparison6SEC filing
Jul 28, 2023Initial$1,700,088No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-568468
On June 4, 2025, the company entered into a securities purchase agreement, as amended on October 5, 2025, pursuant to which the company agreed to issue 12,083 ordinary shares, par value NIS 0.01 per share, for the price of $60.00 per share.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
NoneNone

Source: Form D, filed Dec 30, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Shalom Auerbach Director
Dr. Barak Azmon Director
Dr. Hagit Deutsch Director
Dr. Assaf Deutsch Director, Executive
Prof. Eyal Gur Executive
Nikolai Kunicher Executive
Michal Marks Director, Executive
James Mazzo Director
Shachar Paz Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
3 Hatamar Street
Even Yehuda, L3, 4050003